0000000001264837

AUTHOR

Antonino Musolino

showing 10 related works from this author

Abstract OT-31-01: A phase II study to evaluate the efficacy and safety of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer: P…

2021

Abstract Background Considering the high proportion of tumor-infiltrating lymphocytes (TILs) in BRCA-related breast cancer, we expect that PD-1 pathway is highly expressed and PD-1 antagonist pembrolizumab could provide clinical activity in this kind of tumor. Furthermore, BRCA-related breast cancers are known to be more sensitive to platinum-derived drugs. Thus the association between Pembrolizumab and Carboplatin in metastatic BRCA-related breast cancer seems to be active in this setting of patients. This study will evaluate the safety and the efficacy of Pembrolizumab associated with Carboplatin in BRCA mutated or with unknown mutations metastatic breast cancer patients. Study and Statis…

OncologyCancer Researchmedicine.medical_specialtyPerformance statusbusiness.industryCancerPhases of clinical researchPembrolizumabmedicine.diseaseMetastatic breast cancerCarboplatinchemistry.chemical_compoundRegimenBreast cancerOncologychemistryInternal medicinemedicinebusinessCancer Research
researchProduct

Numerical Analysis of a Transposed Multiwired Armature in Electromagnetic Rail Launchers

2020

Solid armatures in electromagnetic rail launchers have to undergo severe electromagnetic, mechanical, and thermal stresses. These stresses are unevenly distributed in the armature mainly due to the velocity skin effect. Contrasting this effect reduces the peak to average ratio of the stresses and allows better performance of the device. In this article, the behavior of a transposed multiconductor solid armature is numerically investigated by the research code electric network for electromagnetics (EN4EM) developed at the Department of Energy, System, Territory and Construction Engineering (DESTEC), University of Pisa, Pisa, Italy. The code is based on an integral formulation that reduces th…

PhysicsNuclear and High Energy PhysicsComputational electromagnetics; coupled electromechanical analysis; electromagnetic launch; rail launcher; velocity skin effect (VSE)ElectromagneticsComputationNumerical analysisMechanicselectromagnetic launchSettore ING-IND/32 - Convertitori Macchine E Azionamenti Elettricicoupled electromechanical analysisCondensed Matter Physics01 natural sciences010305 fluids & plasmaslaw.inventionComputational electromagneticslaw0103 physical sciencesThermalrail launcherSkin effectComputational electromagnetics coupled electromechanical analysis electromagnetic launch rail launcher velocity skin effect (VSE)Current densityElectrical conductorvelocity skin effect (VSE)Armature (electrical engineering)
researchProduct

A comparison among different kinds of stator lamination in tubular linear machines

2016

In this paper the authors perform a comparison among three different stator structures for a Tubular Permanent Magnet Linear Machine. Each structure is characterized by its own lamination which is expected to contribute to the overall performance of the machine. A detailed analysis of the main figures of merit of the three configurations has been carried out in order to identify the configuration with the best characteristics. Significant data such as flux distribution, rated voltage and current, force on the moved and power losses have been compared. The results show that the choice of a mixed stator lamination allows to improve the performance of these machines.

Electronic Optical and Magnetic Materials; Condensed Matter PhysicsFlux distributionStator laminationTubular linear machinesComputer scienceStator020209 energy02 engineering and technologyRated voltageLamination (topology)Settore ING-IND/32 - Convertitori Macchine E Azionamenti ElettriciCondensed Matter PhysicsStator structureLinear machineElectronic Optical and Magnetic Materialslaw.inventionPermanent magnetPower-losselawFigures of meritElectronic0202 electrical engineering electronic engineering information engineeringOptical and Magnetic MaterialsComposite materialLaminating
researchProduct

RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012

2021

OncologyCancer Researchmedicine.medical_specialtybusiness.industryHematologyGeneral Medicinemedicine.diseasePopulation based studyOncologyInternal medicinemedicineNeoplasmbusinessThyroid cancerHematological Oncology
researchProduct

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

2021

Abstract Purpose Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC accounts for approximately 20% of newly diagnosed breast cancers and is associated with younger age at diagnosis, greater recurrence risk and shorter survival time. Therapeutic options are very scarce. Aim of the present analysis is to provide further insights into the clinical activity of metronomic chemotherapy (mCHT), in a real-life setting. Methods We used data included in the VICTOR-6 study for the present analysis. VICTOR-6 is an Italian multicentre retrosp…

OncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsTriple Negative Breast NeoplasmsVinorelbineCapecitabine; Cyclophosphamide; Methotrexate; Metronomic chemotherapy; Triple-negative breast cancer; Vinorelbine; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cyclophosphamide; Female; Humans; Receptor ErbB-2; Retrospective Studies; Breast Neoplasms; Triple Negative Breast NeoplasmsCapecitabineErbB-2Breast cancerTriple-negative breast cancerRetrospective StudieInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalCyclophosphamideTriple-negative breast cancerCapecitabineRetrospective StudiesAntineoplastic Combined Chemotherapy Protocolbusiness.industryMetronomic chemotherapyVinorelbinemedicine.diseaseClinical TrialMetronomic ChemotherapyMetastatic breast cancerRegimenMethotrexateOncologyFemalebusinessBreast NeoplasmHumanReceptormedicine.drug
researchProduct

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patient…

2020

<b><i>Background:</i></b> Different studies suggest that fulvestrant 500 mg every 28 days (HD-FUL) could be an active treatment in HR+ advanced breast cancer (ABC) patients even treated with aromatase inhibitors in the adjuvant setting. The aim of this analysis is to describe the outcome of ABC patients treated with HD-FUL as first-line treatment in terms of median duration of treatment and the overall response rate in a real-world setting. <b><i>Methods:</i></b> For the purpose of the present analysis, we considered two data sets of HR+ ABC patients collected in Italy between 2012 and 2015 (EVA and GIM-13 AMBRA studies). <b><i>Res…

Oncologymedicine.medical_specialtymedicine.drug_classPopulationAnastrozoleNOInternal medicineFulvestrant · First-line setting · Hormone receptor positive Advanced breast cancermedicineAdjuvant therapyProgression-free survivaleducationFulvestrantFirst-Line settingeducation.field_of_studyHormone receptor positiveAromatase inhibitorFulvestrantEVAbusiness.industrytrialsCancerEndocrine TherapyGIM-13medicine.diseaseEndocrine Therapy HR+/HER2– Advanced Breast Cancer High-Dose Fulvestrant First-Line setting EVA GIM-13 AMBRA trialsAdvanced breast cancer; First-line setting; Fulvestrant; Hormone receptor positiveOncologyHR+/HER2–Advanced Breast CancerSurgeryAMBRAbusinessHigh-DoseTamoxifenResearch Articlemedicine.drug
researchProduct

Electromechanical Numerical Analysis of an Air-Core Pulsed Alternator via Equivalent Network Formulation

2017

In this paper, the numerical analysis on an air-core pulsed alternator is presented. Since compulsators are characterized by very fast electromechanical transients, their accurate analysis requires strong coupling between the equations governing the electrical and the mechanical behaviors. The device is investigated by using a dedicated numerical code capable to take into account eddy currents, compensating windings, as well as the excitation/control circuits. Furthermore, the code is capable of modeling centrifugal forces and vibrations acting on the shaft due to electric and mechanical unbalances or to misalignments of the shaft from its centered position. This makes the code a very power…

Alternator (automotive)Nuclear and High Energy PhysicsAir-core machine020209 energyMechanical engineeringCompensated pulsed alternator02 engineering and technologySettore ING-IND/32 - Convertitori Macchine E Azionamenti Elettrici01 natural sciencescoupled analysiseddy current010305 fluids & plasmaslaw.inventionintegral formulationlawPosition (vector)0103 physical sciences0202 electrical engineering electronic engineering information engineeringEddy currentcompulsatorNuclear and High Energy PhysicElectronic circuitPhysicsnumerical modelsAir-core machine; compulsator; coupled analysis; eddy currents; integral formulation; numerical modelsbusiness.industryNumerical analysisElectrical engineeringeddy currentsCondensed Matter PhysicsVibrationcoupled analysiElectromagnetic coilnumerical modelbusiness
researchProduct

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

2019

Abstract Background The 8th edition of the American Joint Committee on Cancer (AJCC) staging has introduced prognostic stage based on anatomic stage combined with biologic factors. We aimed to validate the prognostic stage in HER2-positive breast cancer patients enrolled in the ShortHER trial. Methods The ShortHER trial randomized 1253 HER2-positive patients to 9 weeks or 1 year of adjuvant trastuzumab combined with chemotherapy. Patients were classified according to the anatomic and the prognostic stage. Distant disease-free survival (DDFS) was calculated from randomization to distant relapse or death. Results A total of 1244 patients were included. Compared to anatomic stage, the prognost…

OncologySettore MED/06 - Oncologia Medicamedicine.medical_treatmentlcsh:MedicineAntineoplastic Agents Immunological0302 clinical medicineBreast cancerTrastuzumabAntineoplastic Combined Chemotherapy Protocols8th AJCC030212 general & internal medicineStage (cooking)8th AJCC; Breast cancer; HER2-positive; Prognostic stage; TrastuzumabGeneral MedicineMiddle AgedPrognosisImmunologicalLocal030220 oncology & carcinogenesisFemaleResearch Articlemedicine.drugAdultmedicine.medical_specialtyRandomizationSocio-culturaleAntineoplastic AgentsBreast NeoplasmsDisease-Free Survival03 medical and health sciencesBreast cancerInternal medicinePrognostic stagemedicineAdjuvant therapyHumanserbB-2AgedNeoplasm StagingCancer stagingChemotherapybusiness.industrylcsh:RCancerGenes erbB-2Trastuzumabmedicine.diseaseHER2-positive Breast cancer Trastuzumab Prognostic stage 8th AJCCHER2-positiveNeoplasm RecurrenceGenesNeoplasm Recurrence Localbusiness
researchProduct

Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998–2012

2021

Abstract Background The number of patients living after a cancer diagnosis is increasing, especially after thyroid cancer (TC). This study aims at evaluating both the risk of a second primary cancer (SPC) in TC patients and the risk of TC as a SPC. Methods We analyzed two population‐based cohorts of individuals with TC or other neoplasms diagnosed between 1998 and 2012, in 28 Italian areas covered by population‐based cancer registries. Standardized incidence ratios (SIRs) of SPC were stratified by sex, age, and time since first cancer. Results A total of 38,535 TC patients and 1,329,624 patients with other primary cancers were included. The overall SIR was 1.16 (95% CI: 1.12–1.21) for SPC i…

MaleOncologyCancer Researchmedicine.medical_specialtypopulation-based cancer registriesPopulationSocio-culturaleSettore MED/42 - Igiene Generale E ApplicataHistory 21st CenturyCohort StudiesRisk FactorsProstateInternal medicinepopulation‐based cancer registriesmedicinethyroid cancerHumanscancer survivorsRadiology Nuclear Medicine and imagingRegistriesThyroid NeoplasmsOverdiagnosiseducationThyroid cancerResearch ArticlesRC254-282cancer survivors; Italy; population-based cancer registries; relative risk; second primary cancer; thyroid cancereducation.field_of_studycancer survivors Italy population-based cancer registries relative risk second primary cancer thyroid cancerbusiness.industryIncidenceIncidence (epidemiology)ThyroidNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerNeoplasms Second PrimaryHistory 20th Centurymedicine.diseaserelative riskmedicine.anatomical_structureOncologyItalyRelative riskFemalesecond primary cancerbusinessCancer PreventionResearch Article
researchProduct

MOESM1 of Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

2019

Additional file 1. Summary of details of studies aimed at evaluating the American Joint Committee on Cancer (AJCC) 8th edition breast cancer prognostic staging.

researchProduct